Was ESG a stock market vaccine during COVID-19?

Alex Fidgeon-Keeler, Associate (London)

We summarise findings from a recent academic work that investigated whether ESG investing offered funds any resilience during the COVID-19 crisis.

In this Literature Review, we discuss the August 2020 paper titled